HCV NS3 protease inhibitors
US9040479B2 · kind B2 · utility
0Cited by
9References
8Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 11, 2013 |
| Grant date | May 26, 2015 |
| Priority date | — |
| Expiry date | Jan 11, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D403/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to compounds, compositions and methods for treating or preventing HCV viral infections in human patients or other animal hosts.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.